Eli Lilly’s Jaypirca (pirtobrutinib) has been recommended by the European Medicines Agency’s (EMA) human medicines committee ...

Novo Nordisk and Gensaic have entered into a partnership worth up to $354m to develop new therapies for cardiometabolic ...

Regeneron Pharmaceuticals has received a positive opinion from the European Medicines Agency’s human medicines committee for ...

The Healthcare Communications Association has recently revitalised its long-established efforts to evaluate impact (those of ...

One of the toughest challenges of educating many African women about female cancers and disease prevention is overcoming ...

But ineffective marketing is, in the words of one CEO I interviewed, a ‘wombat’; a waste of money, brains and time that ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products ...

BeiGene’s Tevimbra (tislelizumab-jsgr) has been approved by the US Food and Drug Administration (FDA) as part of a first-line ...

Roche’s Genentech unit has received approval from the US Food and Drug Administration (FDA) for TNKase (tenecteplase) in ...

Luto, a patient-centred healthcare communications agency, has announced the opening of a new office in Basel, Switzerland, ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Galderma’s Nemluvio (nemolizumab) to treat both ...

Sobi’s Sanofi-partnered Altuvoct (efanesoctocog alfa) has been recommended by the National Institute for Health and Care ...